Economic evaluation of the GENESIS-SEFH report of olaratumab with doxorubicin in soft tissue sarcoma in advanced stages

Economic evaluation of the GENESIS-SEFH report of olaratumab with doxorubicin in soft tissue sarcoma in advanced stages

Objective: The economic evaluation of the drug olaratumab is carried out in the treatment of soft tissue sarcoma. Method: The data were analyzed following the recommendations contained in the MADRE program of the GENESIS-SEFH report model. Results: Progression free survival and overall survival r...

Full description

Bibliographic Details
Main Authors: Juan Carlos del Río-Valencia, Rocío Asensi-Díez, M.ª Dolores Fraga-Fuentes, Ana Clopés-Estela, Lorenzo Villalobos-Torres
Format: Article
Language:English
Published: Grupo Aula Médica 2018-09-01
Series:Farmacia Hospitalaria
Subjects:
Olaratumab
Soft tissue sarcoma
Cost-effectiveness
Online Access:http://www.aulamedica.es/fh/pdf/10917.pdf

Internet

http://www.aulamedica.es/fh/pdf/10917.pdf

Similar Items